Aliaxis

Tonix names CEO's son George Lederman EVP to lead AI and deals

Image
Tonix names CEO's son George Lederman EVP to lead AI and deals

BERKELEY HEIGHTS -- November 19, 2026 -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) appointed George Lederman, Ph.D., as Executive Vice President, Strategy and Transformation, effective October 30, 2026. He is the son of Seth Lederman, M.D., Tonix's President, CEO and Chairman. The company announced the hire on November 2, three days after the start date.

Lederman takes charge of AI, cost management and business development

George Lederman will lead AI initiatives across the organization, with the stated aim of improving operational efficiency and managing costs. He will also run business development, including evaluating partnerships and licensing deals meant to advance clinical programs and share development costs.